Philips Set to Showcase AI-Based Solutions at Arab Health 2020
Company highlights CT, image-guided therapy, and enterprise imaging solutions.
DUBAI – Philips Healthcare is set to highlight several product offerings during the Arab Health 2020 annual meeting.
During the conference, the company will present its artificial intelligence (AI)-based solutions intended to improve patient care and care delivery. The overall goal, according to company information, is to develop integrated solutions that can adapt to customer needs and embed into individual workflows.
Over the next few days, conference attendees will have the opportunity review these Philips products:
- Azurion with FlexArm: This gantry development on Philips’ Azurion platform adds new imaging and patient positioning opportunities. It includes a set of innovations that facilitates performing 2D and 3D imaging across the whole patient.
- IQon Elite Spectral CT: As the industry’s only spectral detector-based CT system, it pairs conventional CT images with layers of spectral results in the same exam, potentially reducing the cost associated with repeat exams.
In addition, the company will showcase:
- Next-generation enterprise imaging informatics, including a suite of integrated products with a comprehensive platform designed to connect clinical capabilities and optimize workflows
- PerformanceBridge, Philips’ vendor-agnostic, integrated, scalable portfolio of analytics, services, and tools that gives hospital departments real-time information for performance improvement
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
